Analysis

3 Takeaways In Ruling On PTAB Standing And Burden-Shifting

By Ryan Davis (September 26, 2018, 8:36 PM EDT) -- The Federal Circuit's recent decision reversing a Patent Trial and Appeal Board ruling that DuPont failed to prove a rival's chemical patent was invalid sheds light on standing requirements for PTAB appeals and when the burden shifts to patentees. Here's what attorneys can learn from the ruling....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!